Search Results

An Interview With Jason H. Rogers, MD

Dr. Rogers, a next-generation interventional cardiologist, shares his insights on percutaneous valvular treatments, his role in the ZEN trial, and future coronary/cardiac developments.

Forward-Looking IVUS in Chronic Total Occlusions

A new approach to an old problem.

By Jason H. Rogers, MD

Side Branch Access

Techniques for achieving side branch access when anatomy is technically challenging.

By Khung Keong Yeo, MBBS, and Jason H. Rogers, MD

Current Catheter-Based Treatments of Functional Mitral Regurgitation

Percutaneous approaches for managing mitral valve disease.

By Jeffrey A. Southard, MD, and Jason H. Rogers, MD

Percutaneous Coronary Intervention of a Chronic Total Occlusion

Treatment of a CTO in the left anterior descending artery.

By Khung Keong Yeo, MBBS, and Jason H. Rogers, MD

Structural Heart Disease: How Do I Get Training?

Dedicated training programs are few and lack standardization, but there are other ways to gain experience.

By Jason H. Rogers, MD, FACC, FSCAI

Next-Generation Percutaneous Mitral and Tricuspid Valve Repair Approaches

What's next for transcatheter management of mitral and tricuspid valve disease.

By Thomas W. Smith, MD; Steven F. Bolling, MD; and Jason H. Rogers, MD

Next-Generation Transcatheter Aortic Valves

A preview of the latest devices that are expected to change the practice of transcatheter valve replacement.

By Ehrin J. Armstrong, MD, MSc, and Jason H. Rogers, MD

The Use of Ultrasound Guidance for Targeted Femoral Access

This technique has gained popularity due to its ability to mitigate the risk of complications.

By Gagan D. Singh, MD, and Jason H. Rogers, MD

Percutaneous Closure of Mitral Prosthetic Paravalvular Leak

A discussion of the disease etiology, treatment techniques, and outcomes of percutaneous PVL repair, as well as an illustrative case report.

By Reza Sepehrdad, MD, and Jason H. Rogers, MD

How Heart Teams Are Adjusting to a Changing Landscape

Experts provide their views on current challenges facing heart teams and expanding from a transcatheter aortic heart valve clinic to including structural heart valve procedures.

With Ganesh Manoharan, MD; Issam D. Moussa, MD; and Jason H. Rogers, MD

Transcatheter Heart Valve Landscape

By Ted E. Feldman, MD, MSCAI, FACC, FESC

Chief Medical Editor's Page: Transcatheter Valve Update

By Ted E. Feldman, MD, FSCAI

Optimal Access/Reliable Closure

By Ted E. Feldman, MD, MSCAI, FACC, FESC

Structural and Valvular Heart Disease

By Ted E. Feldman, MD, Chief Medical Editor

Transcatheter Valve Therapies

By Ted E. Feldman, MD, FSCAI - Chief Medical Editor

Next-Generation DES Technology

By Ted E. Feldman, MD, FSCAI - Chief Medical Editor

Antithrombotic and Antiplatelet Therapies

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

CHIEF MEDICAL EDITOR'S PAGE: Primary PCI for STEMI

Chief Medical Editor's Page: DES Evolution

By Ted E. Feldman, MD, FSCAI